Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Plug Power Pivots, But a Stock Price Reversal Is Unlikely: https://www.marketbeat.com/logos/articles/med_20240304074024_chart-plug-342024ver001.png
Plug Power Pivots, But a Stock Price Reversal Is Unlikely

Plug Power (NASDAQ: PLUG) shares shot up 10% following the Q4 release and FY update; however, it is not time to buy this stock in any other way than speculatively. The company turned a corner and

Target Stock Has a Plan to Compound Your Investment: https://www.marketbeat.com/logos/articles/med_20240301101618_target-stock-has-a-plan-to-compound-your-investmen.jpg
Target Stock Has a Plan to Compound Your Investment

Investing in stocks differs from buying bonds and other vehicles like commodities because they are exposed to two different cycles. Bonds perform based on the credit cycle set by the Federal

Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73815/AC-040324.001.png
Kohl’s Corporation: This Offprice Retailer Is Ready To Rally: https://www.marketbeat.com/logos/articles/med_20240301091400_chart-kss-312024ver001.png
Kohl’s Corporation: This Offprice Retailer Is Ready To Rally

Kohl’s Corporation (NYSE: KSS) stock price has been wallowing near long-term lows despite signs of turnaround and an improving outlook for cash flow. This market needs a catalyst to get it moving

5 Ways Ralph Lauren stock is Dressed for Success: https://www.marketbeat.com/logos/articles/med_20240301083323_5-ways-ralph-lauren-stock-is-dressed-for-success.jpg
5 Ways Ralph Lauren stock is Dressed for Success

Ralph Lauren Corp. (NYSE: RL) stock is in a buy range after its first pullback since gapping up almost 17% following better-than-expected fiscal third-quarter results.

The clothing maker, whose

Nvidia's Soaring Success: Too Late to Buy?: https://www.marketbeat.com/logos/articles/med_20240301081214_nvidias-soaring-success-too-late-to-buy.jpg
Nvidia's Soaring Success: Too Late to Buy?

At the forefront of the market surge stands Nvidia (NASDAQ: NVDA), continuing its meteoric rise into the new year. Last year’s champion stock has wasted no time in extending its winning streak,

3 Stocks Showing Constructive Pullbacks with Indexes at New Highs: https://www.marketbeat.com/logos/articles/med_20240301101105_3-stocks-showing-constructive-pullbacks-with-index.jpg
3 Stocks Showing Constructive Pullbacks with Indexes at New Highs

One of the most exciting things for an investor or trader is to look at tier account statement, or at the charts of what they own, and see a stock like Nvidia Corp. (NASDAQ: NVDA) or even the

3 Hot Stocks Bought by Members of Congress: Follow the Money: https://www.marketbeat.com/logos/articles/med_20240229123055_chart-spg-2292024ver001.png
3 Hot Stocks Bought by Members of Congress: Follow the Money

The STOCK Act of 2012 was supposed to halt insider trading by members of Congress, but let’s be honest. The STOCK Act can’t really stop Congresspeople from trading on insider knowledge; they’re in

Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73797/AC-010324.001.png
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 503% Biotech Aktientip nach 134.452% mit Biogen

 

01.03.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Salesforce.com Stock Will Set a New High This Year: https://www.marketbeat.com/logos/articles/med_20240229093245_chart-crm-2292024ver001.png
Salesforce.com Stock Will Set a New High This Year

Salesforce.com’s (NYSE: CRM) stock price is having trouble with traction following the Q4 results and guidance, but a massive correction is not expected for this tech stock. The results did not

bluebird bio Stock Signals Potential to be a Multi-bagger: https://www.marketbeat.com/logos/articles/med_20240229085127_bluebird-bio-stock-signals-potential-to-be-a-multi.jpg
bluebird bio Stock Signals Potential to be a Multi-bagger

It isn’t often that you can find the right story at the right time to give you a good chance of multiplying your wealth; these so-called multi-bagger stocks get their name because their price sees

Amazon Stock: Why it's Finally Included in the Dow Index: https://www.marketbeat.com/logos/articles/med_20240228144806_amazon-stock-and-why-its-finally-included-in-the-d.jpg
Amazon Stock: Why it's Finally Included in the Dow Index

Does the recent addition of Amazon Inc. (NASDAQ: AMZN) to the Dow Jones Industrial Average signal that the 30-stock index is still relevant?

And what does the addition mean for Amazon stock?

Ross Stores a Pre-earnings Buy with this Specific Strategy?: https://www.marketbeat.com/logos/articles/med_20240228150000_ross-stores-a-pre-earnings-buy-with-this-specific.jpg
Ross Stores a Pre-earnings Buy with this Specific Strategy?

While our readers will be well used to hearing how the hottest tech stocks are back trading at all-time highs, there are few stocks from the more traditional industries doing the same thing. Take

PANW Profits from Pelosi: Former House Speaker’s Recent Trades: https://www.marketbeat.com/logos/articles/med_20240228101745_panw-profits-from-pelosi-learn-the-former-house-sp.jpg
PANW Profits from Pelosi: Former House Speaker’s Recent Trades

Despite some ethical concerns, U.S. Senate and House of Representatives members frequently buy and sell stocks of publicly traded companies, often with fantastic returns. 

Elected officials'

How to Use Credit Spreads to Make Income from Options: https://www.marketbeat.com/logos/articles/med_20240227115611_option-cs-intc.jpg
How to Use Credit Spreads to Make Income from Options

If you are bullish on any optionable stock in any stock sector, you can play any number of options trades. The easiest directional strategy is to buy a call option. However, you will fight time

Insider selling at JPM: A Closer Look Amidst Historic CEO Sale: https://www.marketbeat.com/logos/articles/med_20240228071044_insider-selling-at-jpm-a-closer-look-amidst-histor.jpg
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale

The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock

3 wealth-compounding stocks to beat the market this decade: https://www.marketbeat.com/logos/articles/med_20240226123613_3-wealth-compounding-stocks-to-beat-the-market-thi.jpg
3 wealth-compounding stocks to beat the market this decade

Because the Federal Reserve (the Fed) has announced potential interest rate cuts for this year, an expectation priced in for March is now being pushed as far back as May or June, according to the 

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73761/AC_Vidac_280224.001.png
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

28.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Autozone stock price is still in the rally zone: https://www.marketbeat.com/logos/articles/med_20240227110105_chart-azo-22272024ver001.png
Autozone stock price is still in the rally zone

Autozone (NYSE: AZO) shares surged following the FQ2 report, confirming the uptrend is intact. Because the news aligns with the outlook for growth and capital returns, the trend will likely

Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties: https://www.irw-press.at/prcom/images/messages/2024/73753/Westward_022724_ENPRcom.002.png
Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties

Vancouver, British Columbia, February 27, 2024 – Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to provide preliminary details surrounding

New highs are coming for Lowe’s stock despite mixed results: https://www.marketbeat.com/logos/articles/med_20240227090542_chart-low-2272024ver001.png
New highs are coming for Lowe’s stock despite mixed results

At face value, Lowe’s Companies (NYSE: LOW) had a rough Q4 compared to competitor Home Depot, but the details within the report belie that assessment. Comps were weak, but the company is building

Goldman upgraded Nvidia stock, one metric says it could go higher: https://www.marketbeat.com/logos/articles/med_20240227091342_goldman-upgraded-nvidia-stock-one-metric-says-it-c.jpg
Goldman upgraded Nvidia stock, one metric says it could go higher

Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)

bluebird bio: How to play LEAPS options for growth and income: https://www.marketbeat.com/logos/articles/med_20240226111048_option-blue-stock.jpg
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

Thinking long-term? Don't lose interest in Pinterest: https://www.marketbeat.com/logos/articles/med_20240226120753_thinking-long-term-dont-lose-interest-in-pinterest.jpg
Thinking long-term? Don't lose interest in Pinterest

Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst